Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catrin Hasselgren

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Journal of Chemical Information and Modeling|February 5, 2014
Assessment of machine learning reliability methods for quantifying the applicability domain of QSAR regression modelsMarko Toplak, Rok Močnik, Matija Polajnar, et al.
ALTEX|August 12, 2024
A proof-of-concept rat toxicity study highlights the potential utility and challenges of virtual control groupsRoxanne Andaya, Ruth Sullivan, Tony Pourmohamad, et al.
Drug Metabolism Reviews|March 17, 2007
State-of-the-art tools for computational site of metabolism predictions: comparative analysis, mechanistical insights, and future applicationsLovisa Afzelius, Catrin Hasselgren Arnby, Anders Broo, et al.
Regulatory Toxicology and Pharmacology : RTP|October 15, 2020
Management of pharmaceutical ICH M7 (Q)SAR predictions - The impact of model updatesCatrin Hasselgren, Joel Bercu, Alex Cayley, et al.
Journal of Computer-Aided Molecular Design|November 24, 2007
Generation of in-silico cytochrome P450 1A2, 2C9, 2C19, 2D6, and 3A4 inhibition QSAR modelsM Paul Gleeson, Andrew M Davis, Kamaldeep K Chohan, et al.
Regulatory Toxicology and Pharmacology : RTP|February 11, 2012
In silico methods combined with expert knowledge rule out mutagenic potential of pharmaceutical impurities: an industry surveyKrista L Dobo, Nigel Greene, Charlotta Fred, et al.
Archives of Toxicology|May 14, 2026
Transforming animal study toxicology reports into structured, harmonized data using large language modelsTatyana Y Doktorova, Ilya Schneider Chernov, Alberto Formaggio, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2015
Synchronous down-modulation of miR-17 family members is an early causative event in the retinal angiogenic switchDiana N Nunes, Emmanuel Dias-Neto, Marina Cardó-Vila, et al.
PDA Journal of Pharmaceutical Science and Technology|January 15, 2022
Development of Duration-Based Non-Mutagenic Thresholds of Toxicological Concern (TTCs) Relevant to Parenteral Extractables and Leachables (E&Ls)Melisa J Masuda-Herrera, Joel P Bercu, Thomas H Broschard, et al.
Regulatory Toxicology and Pharmacology : RTP|April 27, 2022
Corrigendum to a cross-industry collaboration to assess if acute toxicity (Q)SAR models are fit-for-purpose for GHS classification and labelling. Regulatory toxicology and pharmacology (2021) 104843Joel Bercu, Melisa J Masuda Herrera, Alejandra Trejo-Martin, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Journal of Chemical Information and Modeling|February 5, 2014
Assessment of machine learning reliability methods for quantifying the applicability domain of QSAR regression modelsMarko Toplak, Rok Močnik, Matija Polajnar, et al.
ALTEX|August 12, 2024
A proof-of-concept rat toxicity study highlights the potential utility and challenges of virtual control groupsRoxanne Andaya, Ruth Sullivan, Tony Pourmohamad, et al.
Drug Metabolism Reviews|March 17, 2007
State-of-the-art tools for computational site of metabolism predictions: comparative analysis, mechanistical insights, and future applicationsLovisa Afzelius, Catrin Hasselgren Arnby, Anders Broo, et al.
Regulatory Toxicology and Pharmacology : RTP|October 15, 2020
Management of pharmaceutical ICH M7 (Q)SAR predictions - The impact of model updatesCatrin Hasselgren, Joel Bercu, Alex Cayley, et al.
Journal of Computer-Aided Molecular Design|November 24, 2007
Generation of in-silico cytochrome P450 1A2, 2C9, 2C19, 2D6, and 3A4 inhibition QSAR modelsM Paul Gleeson, Andrew M Davis, Kamaldeep K Chohan, et al.
Regulatory Toxicology and Pharmacology : RTP|February 11, 2012
In silico methods combined with expert knowledge rule out mutagenic potential of pharmaceutical impurities: an industry surveyKrista L Dobo, Nigel Greene, Charlotta Fred, et al.
Archives of Toxicology|May 14, 2026
Transforming animal study toxicology reports into structured, harmonized data using large language modelsTatyana Y Doktorova, Ilya Schneider Chernov, Alberto Formaggio, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2015
Synchronous down-modulation of miR-17 family members is an early causative event in the retinal angiogenic switchDiana N Nunes, Emmanuel Dias-Neto, Marina Cardó-Vila, et al.
PDA Journal of Pharmaceutical Science and Technology|January 15, 2022
Development of Duration-Based Non-Mutagenic Thresholds of Toxicological Concern (TTCs) Relevant to Parenteral Extractables and Leachables (E&Ls)Melisa J Masuda-Herrera, Joel P Bercu, Thomas H Broschard, et al.
Regulatory Toxicology and Pharmacology : RTP|April 27, 2022
Corrigendum to a cross-industry collaboration to assess if acute toxicity (Q)SAR models are fit-for-purpose for GHS classification and labelling. Regulatory toxicology and pharmacology (2021) 104843Joel Bercu, Melisa J Masuda Herrera, Alejandra Trejo-Martin, et al.
Pageof 3